Summary & Overview
CPT 78121: Red Cell Volume Measurement, Multiple Sample Method
CPT code 78121 denotes a nuclear medicine procedure to measure red cell volume using a multiple-sample radioactive tracer technique. This test quantifies circulating red blood cell volume for diagnostic and treatment planning purposes in hematology and related specialties. Nationally, accurate reporting of this code supports clinical decision-making for anemia evaluation, blood loss assessment, and monitoring of therapies that affect blood volume.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise reference to billing context, typical sites of service, and the clinical role of the procedure. The publication summarizes common payer considerations and available benchmarking where present, outlines coding specifics relevant to claims processing, and situates the service within clinical workflows in hospital outpatient and specialized laboratory settings.
This summary addresses what the code represents, why it matters in patient care and reimbursement workflows, and what practitioners and billing staff should know about documentation and reporting expectations. Data not available in the input is noted where applicable in the full publication.
Billing Code Overview
CPT code 78121 describes a laboratory procedure to determine red cell volume by introducing a known quantity of red blood cells labeled with a radioactive tracer and measuring tracer concentration after adequate mixing. This entry represents the multiple sample method for measuring red blood cell volume and is used to quantify a blood component for clinical assessment.
Service Type: Nuclear medicine / hematology diagnostic test
Typical Site of Service: Hospital outpatient departments, hospital-based laboratories, and specialized diagnostic imaging or nuclear medicine facilities
Clinical & Coding Specifications
Clinical Context
A typical patient is a 65-year-old male referred by a hematologist for measurement of red cell volume (RCV) to evaluate unexplained anemia and to quantify blood loss or red cell mass in cases of suspected polycythemia or hemodilution. The patient arrives at an outpatient nuclear medicine or hospital clinical laboratory. After informed consent, a technologist or nuclear medicine nurse establishes venous access and withdraws baseline blood samples. A known quantity of autologous or homologous red blood cells labeled with a radioactive tracer (commonly chromium-51 or similar) is injected. Multiple timed blood samples are drawn over an interval to allow adequate mixing and equilibration. A laboratory technologist measures radioactivity in the samples to calculate the circulating red cell volume using established decay and dilution equations. The interpreting physician (nuclear medicine physician, hematologist, or pathologist) reviews results, documents the quantitative RCV and interpretation, and communicates findings to the referring clinician for management decisions such as transfusion planning, phlebotomy, or further diagnostic workup.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Office or other outpatient visit for evaluation and management | Use when the physician personally performs a significant, separately identifiable E/M service on the same day as the procedure. |